Gene therapy for vascular disease

Area of Science:

• Cardiovascular Biology
• Molecular Medicine
• Vascular Biology

Background:

• Atherosclerosis involves endothelial dysfunction, inflammation, and plaque formation, leading to ischemic syndromes.
• Advanced atherosclerotic lesions are poorly treated by current therapies, necessitating novel approaches.
• Plaque rupture and thrombosis can precipitate acute ischemic events.

Purpose of the Study:

• To review the current status of gene therapy for atherosclerosis.
• To examine gene therapy's role in addressing vascular proliferation and endothelial dysfunction.
• To explore gene therapy applications for thrombosis, peripheral ischemia, and biomaterial interfaces.

Main Methods:

• Literature review of preclinical and clinical studies on gene therapy for atherosclerosis.
• Analysis of studies focusing on gene delivery vectors and therapeutic targets.
• Evaluation of gene therapy's impact on vascular cell behavior and ischemic outcomes.

Main Results:

• Gene therapy demonstrates potential in modulating vascular cell proliferation and inflammatory responses.
• Studies show promise in restoring endothelial function and reducing thrombosis.
• Gene therapy approaches are being investigated for treating peripheral ischemia and improving biomaterial compatibility.

Conclusions:

• Gene therapy presents a viable strategy for treating complex atherosclerotic disease.
• Further research is needed to optimize delivery and efficacy for clinical application.
• Gene therapy holds potential to address limitations of traditional treatments for advanced atherosclerosis.